Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other Accumulated Expenses (2018 - 2023)

Dna X filings provide 6 years of Other Accumulated Expenses readings, the most recent being $260000.0 for Q3 2023.

  • On a quarterly basis, Other Accumulated Expenses rose 182.61% to $260000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $260000.0, a 182.61% increase, with the full-year FY2022 number at $171000.0, down 49.85% from a year prior.
  • Other Accumulated Expenses hit $260000.0 in Q3 2023 for Dna X, up from $166000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $851000.0 in Q4 2019 to a low of $16000.0 in Q1 2023.
  • Median Other Accumulated Expenses over the past 5 years was $228000.0 (2022), compared with a mean of $293000.0.
  • The widest YoY moves for Other Accumulated Expenses: up 182.61% in 2023, down 94.63% in 2023.
  • Dna X's Other Accumulated Expenses stood at $851000.0 in 2019, then tumbled by 36.66% to $539000.0 in 2020, then plummeted by 36.73% to $341000.0 in 2021, then plummeted by 49.85% to $171000.0 in 2022, then soared by 52.05% to $260000.0 in 2023.
  • The last three reported values for Other Accumulated Expenses were $260000.0 (Q3 2023), $166000.0 (Q2 2023), and $16000.0 (Q1 2023) per Business Quant data.